Monday, July 31, 2017 9:12:40 PM
Marc Tesio is an experienced investment banker who has successfully raised in excess of $50 million of capital for life sciences and other companies. Most recently, he managed a registered direct public offering for Dara Biosciences, Inc., a life science company developing therapeutic treatments for diseases including diabetes. He also acted as financial advisor to ResverLogix, a Canadian biotechnology company that is developing two novel technologies for important global medical markets, and managed a early stage life science investment for Digene Corporation. Prior to his activities in healthcare corporate finance he managed a syndicate desk and oversaw trading and settlements serving international banks and European based institutional portfolio managers. He began his career at Oppenheimer. He holds a degree with honors in Financial Management from Old Dominion University. He serves his local community helping non-profit organizations and enjoys amateur Georgia State athletic competitions and his family in Atlanta. He holds the Series 7, 24, 63 and 79 securities licenses.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM